Bovine tuberculosis is a chronic, infectious disease caused by Mycobacterium bovis (M.bovis), it can infect humans, livestock, wildlife, and exotic species.
Unlike other technologies, the Actiphage test does not measure an immune response, but specifically detects the DNA extracted from live Mycobacteria present in circulating blood as a marker of disease.
PBD Biotech is currently in the process of verifying the Actiphage test for the detection of Mycobacterium bovis (bovine TB) and M. avium subsp paratuberculosis (MAP), (Johne’s disease) in cattle blood.
Certification of Actiphage by the World Organisation for Animal Health (OIE) as an internationally recognised diagnostic for bTB is PBD Biotech’s primary focus for animal health.
However, Actiphage is able to detect most other mycobacterial species and has been successfully applied to samples from multiple animal species.
PBD Biotech has proof-of-concept data that the test can be applied to over 20 species, including humans, and remain open to collaboration with researchers and regulators across the globe who want to advance the science and understanding of these devastating diseases.